Identification and In Vivo Validation of Unique Anti-Oncogenic Mechanisms Involving Protein Kinase Signaling and

Son Tran1, Patrick Sipila1, Satbir Thakur1

  • 1Department of Oncology, University of Calgary, Calgary, AB T2N 1N4, Canada.

Cancers
|April 27, 2024
PubMed

Insights

PV-10, a rose bengal sodium formulation, shows potent anti-cancer effects by inducing apoptosis and autophagy. This study elucidates its mechanisms against diverse solid tumors, paving the way for future clinical applications.

Area of Science:

  • Oncology
  • Cancer Therapeutics
  • Molecular Biology

Background:

  • PV-10 (rose bengal sodium) exhibits immunotherapeutic and anti-cancer activity.
  • Clinical trials are ongoing for PV-10 in metastatic melanomas and neuroendocrine cancers.
  • Preclinical data on PV-10's mechanisms against diverse adult solid tumors were lacking.

Purpose of the Study:

  • To investigate PV-10's cytotoxic mechanisms in various adult solid tumor cell lines.
  • To explore PV-10's effects on apoptotic and autophagic pathways.
  • To assess PV-10's impact on cancer cell migration and in vivo tumor growth.

Main Methods:

  • Cytotoxicity assays on human breast, colorectal, head and neck, and testicular cancer cell lines.
  • Analysis of apoptotic and autophagic markers (caspase-mediated PARP cleavage, SQSTM1/p62, beclin-1).
  • Wound healing assays for cell migration and in vivo studies in tumor-bearing mice.

Main Results:

  • PV-10 induced cytotoxicity via apoptosis and autophagy, involving caspase-mediated PARP cleavage, SQSTM1/p62 downregulation, and beclin-1 upregulation.
  • PV-10 reduced WNK1 phosphorylation, inhibiting cancer cell migration.
  • Significant tumor growth inhibition was observed in mice treated with PV-10.

Conclusions:

  • PV-10 exhibits anti-cancer activity through apoptosis and autophagy induction.
  • PV-10 impacts cancer cell migration and in vivo tumor progression.
  • Identified mechanisms and biomarkers support future clinical studies of PV-10.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K